Dermadoctor Inc. is a physician-founded, problem-solving skincare company that creates and distributes clinical-strength, dermatologist-developed products. Founded in 1998 by Dr. Audrey Kunin, a board-certified dermatologist, the company aims to provide effective, non-irritating treatments for a variety of common skin concerns, from aging and acne to keratosis pilaris and hyperpigmentation. Dermadoctor blends medical expertise with cosmetic elegance, offering solutions that are both potent and pleasant to use. Their products are sold through their website, major beauty retailers, and television shopping networks. In 2021, Dermadoctor was acquired by NovaBay Pharmaceuticals, Inc.
The headquarters serves as the primary hub for Dermadoctor's operations, including product development, brand management, marketing, sales, and administrative functions. It's where strategic decisions are made and new skincare formulations are conceptualized.
While specific details are not widely publicized, it's likely a modern office environment equipped to support creative and scientific endeavors, potentially including laboratory facilities for formulation research and quality control. Given its location, it might be part of a commercial or light industrial park.
The work culture is likely influenced by its founder's medical background, emphasizing scientific rigor, innovation, and a customer-centric approach to skincare. It would foster a collaborative environment focused on quality, efficacy, and addressing real skin concerns.
The Kansas City headquarters is central to Dermadoctor's identity and operational efficiency, allowing it to oversee the entire product lifecycle from research and development to marketing and distribution, ensuring adherence to Dr. Kunin's original vision.
Dermadoctor Inc. primarily focuses on the North American market, with a strong presence in the United States through its e-commerce website and partnerships with major beauty retailers like Sephora, Ulta Beauty, and QVC. While direct international office presence is limited, its products reach a global audience through online retailers that ship internationally and potentially through select international distribution partners. The acquisition by NovaBay Pharmaceuticals may lead to expanded global strategies over time.
1901 Vivion Rd
Kansas City
MO
USA
Address: c/o NovaBay Pharmaceuticals, Inc., 2000 Powell Street, Suite 1150
Serves as the corporate headquarters for the parent company, NovaBay Pharmaceuticals, providing strategic direction, financial oversight, and potentially shared services for its subsidiaries, including Dermadoctor.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, DERMAdoctor' leadership includes:
DERMAdoctor has been backed by several prominent investors over the years, including:
Since the acquisition by NovaBay Pharmaceuticals in November 2021, executive leadership for Dermadoctor brand is integrated within NovaBay's structure. Dr. Audrey Kunin continues to play a key role in product development. Major standalone executive hires or exits specific to Dermadoctor in the last 12 months are not widely publicized, with changes more likely at the parent company level.
Discover the tools DERMAdoctor uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Email communication for Dermadoctor Inc. likely follows standard corporate patterns, often utilizing the employee's name within the email address. Post-acquisition, some communications might also originate from or be routed through NovaBay Pharmaceutical's email system (@novabay.com). For direct Dermadoctor inquiries, customer service channels are prominent.
[first_initial][last]@dermadoctor.com or [first].[last]@dermadoctor.com
Format
akunin@dermadoctor.com or audrey.kunin@dermadoctor.com
Example
70%
Success rate
GlobeNewswire • November 4, 2021
NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) announced the acquisition of DERMAdoctor, LLC, a profitable, growing omnichannel skincare company. The acquisition aimed to expand NovaBay's presence in the skincare market and leverage Dermadoctor's established brand and product line....more
NovaBay Pharmaceuticals Press Release • May 9, 2023
In NovaBay Pharmaceuticals' Q1 2023 financial report, Dermadoctor product sales were noted as a component of the company's revenue, indicating its ongoing contribution to the parent company's performance. Net sales from DERMAdoctor products were $0.9 million for the first quarter of 2023....more
NewBeauty • February 13, 2024
Dermadoctor's KP Duty Dermatologist Formulated Body Scrub with Chemical + Physical Exfoliation received a 2024 NewBeauty Award for 'Best Scrub for Keratosis Pilaris,' highlighting the brand's continued recognition for effective, targeted skincare solutions....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including DERMAdoctor, are just a search away.